Cedara gains FDA nod for Web-enabled viewer

Article

The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired

The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired from multiple modalities (such as x-ray, echocardiography, and CT). The viewer supports both static and dynamic (cine) views and has a plug-in architecture, enabling integration of the viewer into other, third-party, products. The Canadian company plans to develop noncardiology applications for the viewer as well.


© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 5.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.